WaferGen's Q4 Revenues Fall Sharply, but Annual Revenues Soar | GenomeWeb

NEW YORK (GenomeWeb News) – WaferGen Bio-systems reported in its 10-K filing with the US Securities and Exchange Commission this week that its fourth-quarter 2008 revenues fell 60 percent, following three successive quarters of significant increases in revenue.

The Fremont, Calif.-based firm brought in revenues of $65,424 for the three-month period ended Dec. 31, 2008, compared to $161,513 for the comparable period the year before. It did not provide a reason in the filing for the sharp year-over-year decline.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.